v3.26.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Jul. 25, 2026
Jul. 26, 2025
Cash flows from operating activities    
Net income (loss) $ (1,984) $ 18,297
Adjustments to reconcile net income to cash provided by operating activities    
(Gain) loss on disposal and impairment of assets 7,120 (92)
(Gain) loss on sale of investments (1,500) (94)
Provision for doubtful accounts 220 129
Depreciation and amortization 12,692 11,329
Amortization of right-of-use lease assets 23,048 20,234
Lease impairment 4,670 0
Equity-based compensation expense 2,927 3,420
Change in deferred taxes 1,577 1,075
Change in receivables 12,763 8,498
Change in inventories (12,241) 3,637
Change in other assets (17,523) (4,805)
Change in payables 15,000 4,653
Change in lease liabilities (22,755) (20,230)
Change in other liabilities (8,366) (9,759)
Net cash provided by operating activities 15,648 36,292
Cash flows from investing activities    
Proceeds from disposals of assets 7,509 170
Capital expenditures (23,284) (18,461)
Purchases of investments (44) (117)
Proceeds from sales of investments 18,483 216
Acquisitions (15,650) (627)
Net cash used for investing activities (12,986) (18,819)
Cash flows from financing activities    
Payments on finance lease liabilities (219) (225)
Payments for debt issuance costs 0 (784)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes (3,075) (5,190)
Repurchases of common stock (25,144) (12,505)
Dividends paid to shareholders (9,672) (9,012)
Net cash used for financing activities (38,110) (27,716)
Effect of exchange rate changes on cash and equivalents (511) 338
Change in cash and cash equivalents (35,959) (9,905)
Cash and cash equivalents at beginning of period 303,213 328,449
Cash and cash equivalents at end of period 267,254 318,544
Supplemental disclosure of non-cash investing activities    
Capital expenditures included in payables $ 4,866 $ 6,233